Guidance for contemporary use of biologics in management of chronic rhinosinusitis with nasal polyps: discussion from a National Institutes of Health–sponsored workshop

Lauren T. Roland, Timothy L. Smith, Rodney J. Schlosser, Zachary M. Soler, Anju T. Peters, Tanya M. Laidlaw, Benjamin S. Bleier, Vijay Ramakrishnan, Elina Toskala, David W. Kennedy, Amber U. Luong

Research output: Contribution to journalReview articlepeer-review

24 Scopus citations

Abstract

Background: Biologic medications are emerging as options for treating chronic rhinosinusitis with nasal polyps (CRSwNP). Several questions remain regarding patient selection, indications, clinical efficacy, and cost effectiveness. Methods: In November 2019, a group of physicians and scientists gathered to consider strategies for future studies regarding biologics. During the discussion, gaps in knowledge highlighted a need for a consensus on the present day use of biologics in polyp patients. Results: The goal of this guideline is to propose recommendations for the current use of biologics in CRSwNP as new evidence continues to emerge and inform practice. Conclusion: We suggest that physicians evaluate patients on an individual basis and closely monitor for improvement due to the high cost and unknown long-term effects of biologics.

Original languageEnglish (US)
Pages (from-to)1037-1042
Number of pages6
JournalInternational Forum of Allergy and Rhinology
Volume10
Issue number9
DOIs
StatePublished - Sep 1 2020

Keywords

  • chronic rhinosinusitis
  • endoscopic sinus surgery
  • guideline
  • medical therapy of chronic rhinosinusitis
  • topical therapy for chronic rhinosinusitis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Otorhinolaryngology

Fingerprint

Dive into the research topics of 'Guidance for contemporary use of biologics in management of chronic rhinosinusitis with nasal polyps: discussion from a National Institutes of Health–sponsored workshop'. Together they form a unique fingerprint.

Cite this